Heinz Albert Duerk - St. Barbara-Klinik Hamm

基本信息

Career Trajectory

Bio

Heinz Albert Duerk currently works at the Hematology and Medical Oncology, St. Barbara-Klinik Hamm. Heinz does research in Multiple Myeloma, Non-Hodgkin-Lymphoma and Leukemia.

Research Interests

Papers共 8 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

P554: RESULTS OF A RANDOMIZED PLACEBO-CONTROLLED PHASE 2 STUDY OF HYPOMETHYLATING AGENTS WITH OR WITHOUT ELTROMBOPAG IN ELDERLY AML PATIENTS (DELTA)

HemaSphereno. S3 (2023)

Cited0Views0Bibtex

Sorafenib or Placebo in Patients with Newly Diagnosed Acute Myeloid Leukaemia: Long-Term Follow-Up of the Randomized Controlled SORAML Trial

Leukemia（2021）

Cited44Views0WOSNATUREBibtex

Donor-cell Leukemia with Novel Genetic Features 2 Years after Sex-Mismatched T Cell-Depleted Haploidentical Stem Cell Transplantation

Verena Luber,Mathias Lutz,Christian Thiede,Claudia Haferlach,Heinz Albert Dürk,Hermann Einsele,Götz Ulrich Grigoleit,Stephan Mielke

Annals of Hematology（2020）

Cited1Views0WOSBibtex

The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial

Blood（2017）

Cited24Views0Bibtex

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial

Bloodno. 22 (2016): 185-185

Cited10Views0Bibtex

Maintenance Therapy for Multiple Myeloma with Particular Emphasis on Thalidomide

Heinz Albert Duerk

Oncology Research and Treatment（2006）

Cited8Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn